A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats.
Elina RubinAgnese C PippioneMatthew BoykoGiacomo EinaudiStefano SainasMassimo CollinoCarlo CifaniMarco L LolliNaim Abu FrehaJacob KaplanskiDonatella BoschiAbed N AzabPublished in: Brain sciences (2021)
These results suggest that NF-κB inhibition is a potential therapeutic strategy for the treatment of ischemic stroke.